Norges Bank and Berkshire Commit $5.4B to UnitedHealth Group as Dodge & Cox Boosts Stake 117.7%
Norges Bank and Berkshire Hathaway initiated UnitedHealth Group positions valued at $3.84B and $1.57B respectively, while Dodge & Cox expanded its stake by 117.7% to 8.75M shares worth $2.73B. Morgan Stanley lifted its price target from $325 to $395 and Royal Bank of Canada raised from $286 to $408.
1. Institutional Buying and Fund Activity
Chemistry Wealth Management LLC increased its position in UnitedHealth Group by 59.2% during the third quarter, adding 6,022 shares to bring its total to 16,199 shares. This stake represents approximately 1.1% of the firm’s overall portfolio and ranks UnitedHealth Group as its 18th largest holding. At the end of the reporting period, this position was valued at $5.59 million, underscoring the fund’s growing conviction in the healthcare conglomerate’s long-term prospects.
2. Hedge Funds and Major Stakes
Several prominent institutional investors have also adjusted their exposure to UnitedHealth Group. Norges Bank initiated a stake valued at $3.84 billion, while Berkshire Hathaway established a new position worth $1.57 billion during the second quarter. Dodge & Cox more than doubled its holdings, increasing its stake by 117.7% to 8.75 million shares, valued at $2.73 billion, and Lone Pine Capital added a $528 million position. Amundi boosted its holdings by 33.8%, acquiring 1.56 million additional shares for a total value of $1.90 billion. These moves leave institutional investors owning nearly 88% of the outstanding stock.
3. Analyst Upgrades and Consensus Views
Wall Street research teams have grown increasingly bullish on UnitedHealth Group. Morgan Stanley upgraded to overweight, lifting its target from 325 to 395, while Royal Bank of Canada moved its target from 286 to 408 with an outperform rating. Goldman Sachs initiated coverage with a buy recommendation and a 406 target, and UBS raised its objective to 430, also rating the company a buy. Overall, seventeen analysts recommend buying, nine suggest holding and three advise selling. The consensus medium-term target stands at approximately 386.
4. Recent Earnings, Profitability and Dividend
In its latest quarterly report, UnitedHealth Group delivered earnings per share of 2.92, surpassing consensus estimates by five cents, and generated revenue of $113.16 billion—up 12.2% year-over-year. The company posted a net margin of 4.04% and a return on equity of 19.23%. Management declared a quarterly dividend of 2.21 per share, translating to an annualized payout of 8.84 and a payout ratio of 46.1%, reflecting a balanced approach to returning capital to shareholders while funding growth in its UnitedHealthcare and Optum platforms.